Cited 12 times in
Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강영애 | - |
dc.contributor.author | 김세규 | - |
dc.contributor.author | 김송이 | - |
dc.contributor.author | 김영삼 | - |
dc.contributor.author | 박무석 | - |
dc.contributor.author | 송주한 | - |
dc.contributor.author | 장준 | - |
dc.contributor.author | 정경수 | - |
dc.date.accessioned | 2017-02-24T11:22:31Z | - |
dc.date.available | 2017-02-24T11:22:31Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1413-8670 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/146752 | - |
dc.description.abstract | Increased serum CA 19-9 levels in patients with nonmalignant diseases have been investigated in previous reports. This study evaluates the clinical significance of serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease and pulmonary tuberculosis. The median CA 19-9 level was higher in patients with pulmonary nontuberculous mycobacterial disease than in patients with pulmonary tuberculosis (pulmonary nontuberculous mycobacterial disease: 13.80, tuberculosis: 5.85, p<0.001). A multivariate logistic regression analysis performed in this study showed that Mycobacterium abscessus (OR 9.97, 95% CI: 1.58, 62.80; p=0.014) and active phase of pulmonary nontuberculous mycobacterial disease (OR 12.18, 95% CI: 1.07, 138.36, p=0.044) were found to be risk factors for serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease. The serum CA 19-9 levels showed a tendency to decrease during successful treatment of pulmonary nontuberculous mycobacterial disease but not in pulmonary tuberculosis. These findings suggest that CA 19-9 may be a useful marker for monitoring therapeutic responses in pulmonary nontuberculous mycobacterial disease, although it is not pulmonary nontuberculous mycobacterial disease-specific marker. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.format.extent | 26~32 | - |
dc.language | English | - |
dc.publisher | Elsevier Editora | - |
dc.relation.isPartOf | BRAZILIAN JOURNAL OF INFECTIOUS DISEASES | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Anti-Bacterial Agents/administration & dosage | - |
dc.subject.MESH | Biomarkers/blood | - |
dc.subject.MESH | CA-19-9 Antigen/blood* | - |
dc.subject.MESH | Drug Therapy, Combination | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Lung Diseases/blood* | - |
dc.subject.MESH | Lung Diseases/drug therapy | - |
dc.subject.MESH | Lung Diseases/microbiology | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Mycobacterium Infections, Nontuberculous/classification* | - |
dc.title | Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease | - |
dc.type | Article | - |
dc.publisher.location | Brazil | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Internal Medicine | - |
dc.contributor.googleauthor | Ji Young Hong | - |
dc.contributor.googleauthor | Sun Hee Jang | - |
dc.contributor.googleauthor | Song Yee Kim | - |
dc.contributor.googleauthor | Kyung Soo Chung | - |
dc.contributor.googleauthor | Joo Han Song | - |
dc.contributor.googleauthor | Moo Suk Park | - |
dc.contributor.googleauthor | Young Sam Kim | - |
dc.contributor.googleauthor | Se Kyu Kim | - |
dc.contributor.googleauthor | Joon Chang | - |
dc.contributor.googleauthor | Young Ae Kang | - |
dc.identifier.doi | 10.1016/j.bjid.2015.09.005 | - |
dc.contributor.localId | A00057 | - |
dc.contributor.localId | A00602 | - |
dc.contributor.localId | A00626 | - |
dc.contributor.localId | A00707 | - |
dc.contributor.localId | A01457 | - |
dc.contributor.localId | A02062 | - |
dc.contributor.localId | A03472 | - |
dc.contributor.localId | A03570 | - |
dc.relation.journalcode | J02850 | - |
dc.identifier.eissn | 1678-4391 | - |
dc.identifier.pmid | 26613892 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S1413867015001944 | - |
dc.subject.keyword | Biological marker | - |
dc.subject.keyword | Carbohydrate antigen 19-9 | - |
dc.subject.keyword | Nontuberculous mycobacteria | - |
dc.subject.keyword | Tuberculosis | - |
dc.contributor.alternativeName | Kang, Young Ae | - |
dc.contributor.alternativeName | Kim, Se Kyu | - |
dc.contributor.alternativeName | Kim, Song Yi | - |
dc.contributor.alternativeName | Kim, Young Sam | - |
dc.contributor.alternativeName | Park, Moo Suk | - |
dc.contributor.alternativeName | Song, Joo Han | - |
dc.contributor.alternativeName | Chang, Joon | - |
dc.contributor.alternativeName | Jung, Kyung Soo | - |
dc.contributor.affiliatedAuthor | Kang, Young Ae | - |
dc.contributor.affiliatedAuthor | Kim, Se Kyu | - |
dc.contributor.affiliatedAuthor | Kim, Song Yi | - |
dc.contributor.affiliatedAuthor | Kim, Young Sam | - |
dc.contributor.affiliatedAuthor | Park, Moo Suk | - |
dc.contributor.affiliatedAuthor | Song, Joo Han | - |
dc.contributor.affiliatedAuthor | Chang, Joon | - |
dc.contributor.affiliatedAuthor | Jung, Kyung Soo | - |
dc.citation.volume | 20 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 26 | - |
dc.citation.endPage | 32 | - |
dc.identifier.bibliographicCitation | BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, Vol.20(1) : 26-32, 2016 | - |
dc.date.modified | 2017-02-24 | - |
dc.identifier.rimsid | 47495 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.